Literature DB >> 21516398

Cytogenetic analysis of cancer cell lines.

Roderick A F Macleod1, Maren Kaufmann, Hans G Drexler.   

Abstract

Cancer genes are often deregulated by genomic rearrangements. Accordingly, analysis of the participant chromosomes responsible now occupies a key role in characterizing and identifying cancer cell lines. Cytogenetics may also be used to study the nature and extent of chromosome breakage induced by radiation or chemicals ("clastogenesis"), to distinguish individual cells or clones within a tumor cell population and to monitor the stability of chromosome rearrangements. This chapter describes cytogenetic procedures for characterizing cancer cells in culture. Cell lines allow the use of a wider range of harvesting and hypotonic treatments to optimize metaphase chromosome preparations than that possible with primary cultures. This assists improved banding, fluorescence in situ hybridization (FISH), and Spectral Karyotyping (SKY) analysis for research, rendering cell lines ideal tools for oncogenomics, ideally in parallel with transcriptomic analysis of the same cells. The experience of the writers with more than 800 cell lines has shown that no single hypotonic harvesting protocol is adequate consistently to deliver satisfactory chromosome preparations. Thus, evidence-based protocols are described for hypotonic harvesting, rapid G-banding, and FISH and SKY analysis of cell cultures to allow troubleshooting and fine-tuning to suit the requirements of individual cell lines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516398     DOI: 10.1007/978-1-61779-080-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.

Authors:  Jie Ding; Wilhelm G Dirks; Stefan Ehrentraut; Robert Geffers; Roderick A F MacLeod; Stefan Nagel; Claudia Pommerenke; Julia Romani; Michaela Scherr; Lea A I Vaas; Margarete Zaborski; Hans G Drexler; Hilmar Quentmeier
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

Review 2.  Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-03-08

3.  Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2015-11-24

4.  Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.

Authors:  Hilmar Quentmeier; Hans G Drexler; Vivien Hauer; Roderick A F MacLeod; Claudia Pommerenke; Cord C Uphoff; Margarete Zaborski; Mattias Berglund; Gunilla Enblad; Rose-Marie Amini
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

5.  Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2016-07-19

6.  Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.

Authors:  Stefan Nagel; Stefan Ehrentraut; Jürgen Tomasch; Hilmar Quentmeier; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

7.  Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.

Authors:  Stefan Nagel; Stefan Ehrentraut; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

8.  NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2017-06-21

9.  Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Margarete Zaborski; Roderick A F MacLeod; Hans G Drexler
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

10.  Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2018-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.